Atropos Health is the developer of the first physician consultation service that delivers publication-grade real-world evidence. Powered by CancerLinQ's millions of anonymized cancer patient records, a joint offering will enable oncology practices and researchers to answer clinical questions that have fallen through the cracks of the evidence-based literature.
Count Me In
Together, CancerLinQ and Count Me In will work to engage more patients into the Count Me In research study through the relationships CancerLinQ has at over 100 Oncology Practices and Hospitals in the United States.
HealthVerity and CancerLinQ are partnering to provide access to CancerLinq Discovery for academic, government and non-profit customers. The HealthVerity IPGE platform, based on the foundational elements of Identity, Privacy, Governance, and Exchange, enables the discovery of real-world data across the broadest healthcare data ecosystem, the building of more complete and accurate patient journeys and the ability to power best-in-class analytics and applications with flexibility and ease.
Owkin is a French-American startup that uses artificial intelligence to find the right treatment for every patient. Our focus is to use AI to discover and develop better treatments for unmet medical needs, starting with the fight against cancer.
We use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, a pioneering collaborative AI framework, Owkin enables biomedical partners and other stakeholders to unlock valuable insights from siloed datasets while protecting patient privacy and securing proprietary data.
Owkin was co-founded by Thomas Clozel MD, a former assistant professor in clinical onco-hematology, and Gilles Wainrib, a pioneer in the field of machine learning in biology, in 2016.